Literature DB >> 21795869

Use of ultra rapid opioid detoxification in the treatment of US military burn casualties.

Christopher V Maani1, Peter A DeSocio, Richard K Jansen, Jason D Merrell, Laura L McGhee, Alan Young, James F Williams, Katie Tyrell, Bonnie A Jackson, Maria L Serio-Melvin, Lorne H Blackbourne, Evan M Renz.   

Abstract

BACKGROUND: The purpose of this case series was to review the management of burn patients who requested ultrarapid opioid detoxification under anesthesia after extended duration of narcotic use for chronic pain related to burn injury.
METHODS: The treatment plan of six opioid-dependent burn patients was analyzed to assess the effectiveness of our detoxification practice to date. Demographic and clinical information was used to characterize the patient population served: age, burn size, injury severity, duration of narcotic use before detoxification intervention, and length of hospitalization stay. Daily narcotic consumption, in morphine equivalent units, was noted both before and after detoxification.
RESULTS: Six burn patients (average age, 31 years) underwent detoxification at the Burn Center during a hospitalization lasting between 1 day and 2 days. Average burn size was 38% total body surface area (range, 17-65); average Injury Severity Score was 30 (range, 25-38). Mean duration of narcotic use was 672 days (range, 239-1,156 days); average use of narcotics at time of detoxification was >200 units daily. Mean outpatient consumption for opioids after the intervention was minimal (<25 units/d). No complications were noted during any procedures.
CONCLUSIONS: The results of ultrarapid opioid detoxification under anesthesia suggests that it is safe and effective for treating opioid addiction in military burn casualties when a coordinated, multidisciplinary approach is used. Safety and effectiveness to date validate current practice and supports incorporation into clinical practice guidelines. Further clinical research is warranted to identify those patients who may benefit most from detoxification and to determine the timing of such treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21795869     DOI: 10.1097/TA.0b013e3182219209

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  3 in total

1.  Patient outcomes after opioid dose reduction among patients with chronic opioid therapy.

Authors:  Sara E Hallvik; Sanae El Ibrahimi; Kirbee Johnston; Jonah Geddes; Gillian Leichtling; P Todd Korthuis; Daniel M Hartung
Journal:  Pain       Date:  2022-01-01       Impact factor: 7.926

2.  Multidisciplinary care for opioid dose reduction in patients with chronic non-cancer pain: A systematic realist review.

Authors:  Abhimanyu Sud; Alana Armas; Heather Cunningham; Shawn Tracy; Kirk Foat; Navindra Persaud; Fardous Hosseiny; Sylvia Hyland; Leyna Lowe; Erin Zlahtic; Rhea Murti; Hannah Derue; Ilana Birnbaum; Katija Bonin; Ross Upshur; Michelle L A Nelson
Journal:  PLoS One       Date:  2020-07-27       Impact factor: 3.240

3.  Efficacy of interventions to reduce long term opioid treatment for chronic non-cancer pain: systematic review and meta-analysis.

Authors:  Nicholas Avery; Amy G McNeilage; Fiona Stanaway; Claire E Ashton-James; Fiona M Blyth; Rebecca Martin; Ali Gholamrezaei; Paul Glare
Journal:  BMJ       Date:  2022-04-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.